<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0000965'>Livedo reticularis</z:hpo> (LR) is a skin vasculopathy that has been frequently described in patients with anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (APS) and reported to be present in association with valvular heart pathology and <z:hpo ids='HP_0001297'>strokes</z:hpo> (i.e. <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: In a cohort of APS patients we investigated the possible association of LR with various clinical aspects of APS such as pregnancy morbidity, central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) and cardiac manifestations </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:hpo ids='HP_0000965'>Livedo reticularis</z:hpo> was found in 50/308 (16%) of APS patients, and there was a significant association with <z:hpo ids='HP_0001297'>cerebrovascular accidents</z:hpo> (<z:chebi fb="4" ids="46274">CVA</z:chebi>), <z:hpo ids='HP_0002076'>migraines</z:hpo> and <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> (p = 0.01, 0.002, and 0.02 respectively) </plain></SENT>
<SENT sid="3" pm="."><plain>A similar association was also detected between LR, and the presence of cardiac valve thickening and vegetations (p = 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>No association with <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, recurrent fetal loss, IUGR or <z:e sem="disease" ids="C0040524,C0032914" disease_type="Disease or Syndrome" abbrv="">toxemia</z:e> was found </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0000965'>Livedo reticularis</z:hpo> is a frequent cutaneous manifestation in patients with APS </plain></SENT>
<SENT sid="6" pm="."><plain>Its high association with cardiac and <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:mp ids='MP_0005048'>thrombosis</z:mp> may suggest that LR-APS patients compose a subset at higher risk for <z:mp ids='MP_0005048'>thrombosis</z:mp>, and thus may require a closer follow-up and a more aggressive anticoagulation </plain></SENT>
</text></document>